Home > Insider Trading > Filing (0001181431-14-016852)

Filing Details

Accession Number:: 0001181431-14-016852
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-04-24 14:59:09
Reporting Period:: 2014-04-22

Filing Date:: 2014-04-24
Accepted Time:: 2014-04-24 14:59:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1432732	Trivascular Technologies Inc.	TRIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1302106	D Ryan Drant	1954 Greenspring Drive Suite 600 Timonium MD 21093		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-22	583,333	$12.00	583,333	No	4	P	Indirect	See Note 1
Common Stock	Acquisiton	2014-04-22	797,208	$0.00	1,380,541	No	4	C	Indirect	See Note 1
Common Stock	Acquisiton	2014-04-22	383,249	$0.00	1,763,790	No	4	C	Indirect	See Note 1
Common Stock	Acquisiton	2014-04-22	531,758	$0.00	2,295,548	No	4	C	Indirect	See Note 1
Common Stock	Acquisiton	2014-04-22	1,236,487	$0.00	3,532,035	No	4	C	Indirect	See Note 1
Common Stock	Acquisiton	2014-04-22	411,234	$0.00	3,943,269	No	4	C	Indirect	See Note 1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Note 1
No	4	C	Indirect	See Note 1
No	4	C	Indirect	See Note 1
No	4	C	Indirect	See Note 1
No	4	C	Indirect	See Note 1
No	4	C	Indirect	See Note 1

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2014-04-22	797,208	$0.00	797,208	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-04-22	383,249	$0.00	383,249	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-04-22	531,758	$0.00	531,758	$0.00
Common Stock	Series D Preferred Stock	Disposition	2014-04-22	1,236,487	$0.00	1,236,487	$0.00
Common Stock	Series E Preferred Stock	Acquisiton	2013-11-01	411,234	$0.00	411,234	$0.00
Common Stock	Series E Preferred Stock	Disposition	2014-04-22	411,234	$0.00	411,234	$0.00
Series D Preferred Stock	Warrant to Purchase Series D Preferred Stock (right to buy)	Disposition	2014-04-22	55,831	$15.81	55,831	$0.00
Common Stock	Warrant to Purchase Common Stock (right to buy)	Acquisiton	2014-04-22	55,831	$0.00	55,831	$15.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
0			No	4	C	Indirect
411,234			No	4	A	Indirect
0			No	4	C	Indirect
0	2012-02-02	2019-02-02	No	4	C	Indirect
55,831	2012-02-02	2019-02-02	No	4	C	Indirect

Footnotes

The Reporting Person is a manager of NEA 12 GP, LLC, which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 12 in which the Reporting Person has no pecuniary interest.
Each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into 0.03845959625192770 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on an as converted basis. The shares have no expiration date.
Each share of Series C Preferred Stock converted in to 0.03899558573514530 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on an as converted basis. The shares have no expiration date.
Each share of Series D Preferred Stock and each share of Series E Preferred Stock converted into 0.02464875523786050 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The number of securities reported in Table II is shown on an as converted basis. The shares have no expiration date.